Enterprise and Innovation Unit
Driving business development and maximising the commercial potential of research
The Enterprise and Innovation Unit supports the translation of discoveries into products, tools and technologies that reach those who need them most
We business development, support innovation, develop market access strategy, and maximise the commercial value of research outputs and intellectual property.
We support and facilitate the translation of research into implemented interventions, build collaborations with industry stakeholders, and work to reduce market access barriers so LSTM’s intellectual property can deliver impact.
We work in line with LSTM’s mission to improve health outcomes in disadvantaged populations, with a particular focus on the needs of low- and middle-income countries (LMICs), and alignment with local and regional health and economic priorities.
Our focus and approaches
We create and direct business opportunities
We create and direct business opportunities that help move research towards market impact.
We manage intellectual property and shape pathways to impact
We maximise the commercial value and impact of intellectual property, supported by market intelligence and direction-setting for pathways to impact.
We build ecosystems that help research translate into use
Our remit includes translational ecosystem development, plus contract research and consultancy activity, to help research move into implementation.
Our team
Dr Becky Jones-Phillips
Dr Becky Jones-Phillips directs the Enterprise and Innovation Unit and is dedicated to accelerating translational research into impactful health innovations. Her career spans global health research, the commercial diagnostics sector, and innovation leadership.
Dr Ezekiel Boro
Ezekiel Boro is the Head of Innovation Capacity Strengthening in the Enterprise and Innovation Unit and oversees the team’s efforts to bolster translational research capacity by developing, implementing or supporting ICS projects and initiatives in collaboration with our partners and other global health stakeholders.